# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Cathie Wood, CEO of Ark Invest, believes healthcare is the most profound application of AI and Wall Street is overlooking its p...
Evercore ISI Group analyst Vijay Kumar maintains Twist Bioscience (NASDAQ:TWST) with a Outperform and lowers the price targe...
-- Launch of End-to-End Workflow for AVITI and AVITI24™ Enabling Sample to Sequencer in as Little as Five Hours ---- Twist Gain...
Cathie Wood-led Ark Invest executed a significant trade in Block Inc. (NYSE:XYZ) on Tuesday.
Twist Bioscience (NASDAQ:TWST) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of $(0....
Twist Bioscience beat Q3 revenue estimates, improved gross margins, and narrowed its full-year outlook while forecasting EBITDA...